AAM
CELG

Archipel Asset Management’s Celgene Corp CELG Stock Holding History

Archipel Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-23,646
Closed -$1.65M – 110
2014
Q1 		$1.65M Buy
+23,646
New +$1.87M 0.43% 59

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Archipel Asset Management's CELG Position: Q2 2014 in Review

Archipel Asset Management sold out of Celgene Corp (CELG) in Q2 2014, closing a stake of 23,646 shares — an estimated $1.65M sold.

Archipel Asset Management first reported a position in CELG in Q1 2014 and held it in 1 quarter. The position peaked at $1.65M in Q1 2014. 995 funds tracked by Wall St. Rank hold CELG as of Q2 2014.

  • Archipel Asset Management reported no remaining Celgene Corp position as of Q2 2014 after selling out during the quarter.
  • Archipel Asset Management sold 23,646 Celgene Corp shares in Q2 2014, an estimated $1.65M.
  • Archipel Asset Management first reported a position in Celgene Corp in Q1 2014 and held it in 1 quarter.
  • Archipel Asset Management's Celgene Corp position peaked at $1.65M in Q1 2014.
  • 995 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2014.

Based on Archipel Asset Management's 13F filing for Q2 2014, filed 6 Aug 2014.